ARCHIVES

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

This article is from The Cancer Letter archive.

Vol. 24 No. 8 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

In Congress: Mack Urges Stevens To Add $2 Billion To NIH Appropriations

June 13, 1997

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

Acting Commissioner Tells Grassley He Supports “Academic Freedom” at The Agency, but “At A Proper Time.”

December 1, 2006

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed

April 4, 1980